120 likes | 355 Vues
ANTIBIOTIC PROPHYLAXIS in Premature Rupture of Membranes. Dr. Geetha Balsarkar, Associate Professor and Unit incharge, Nowrosjee Wadia Maternity Hospital, Seth G.S. Medical college, Parel , Mumbai Joint Asst. Secretary to the Editor, Journal of Obstetrics and Gynecology of India,
E N D
Dr. Geetha Balsarkar, Associate Professor and Unit incharge, Nowrosjee Wadia Maternity Hospital, Seth G.S. Medical college, Parel , Mumbai Joint Asst. Secretary to the Editor, Journal of Obstetrics and Gynecology of India, Secretary, AMWI, Mumbai branch
Premature birth carries substantial neonatal morbidity and mortality. Why? • subclinical infection • To whom? • Mother – chorioamnionitis • Fetus
Flip side • Maternal antibiotic therapy might lessen infectious morbidity and delay labour, but could suppress labour without treating underlying infection.
Cochrane data base • The use of antibiotics following pROM is associated with a statistically significant reduction in chorioamnionitis • There was a reduction in the numbers of babies born within 48 hours • The following markers of neonatal morbidity were reduced: neonatal infection, • use of surfactant • oxygen therapy • and abnormal cerebral ultrasound scan prior to discharge from hospital • Co-amoxiclav was associated with an increased risk of neonatal necrotising enterocolitis
Conclusion • Antibiotic administration following pROM is associated with a delay in delivery and a reduction in major markers of neonatal morbidity. • These data support the routine use of antibiotics in pPROM. • The choice as to which antibiotic would be preferred is less clear as, by necessity, fewer data are available. • Co-amoxiclav should be avoided in women at risk of preterm delivery because of the increased risk of neonatal necrotising enterocolitis. • From the available evidence, erythromycin would seem a better choice.
National Institute of Child Health and Human Development - Maternal Fetal Medicine Units (NICHD-MFMU) study of PROM and the ORACLE trial. • intravenous antibiotics were used for 48 hours—ampicillin 2 g q6h and erythromycin 250 mg q6h. The patients were then placed on oral amoxicillin 250 mg q8h and enteric-coated, erythromycin-base 333 mg q8h to complete a 7-day course of antibiotic therapy.
Current evidence • 7 days of antibiotics, as proposed by the NICHD-MFMU study of PROM, should be the antibiotic regimen used in patients with PPROM who are being managed expectantly. • When another antibiotic is being used for other indications, such as a urinary tract infection, attempts should be made to avoid duplicated therapy. • For example, a patient being treated with a cephalosporin for a urinary tract infection does not need penicillin therapy. • Therapy longer than 7 days should be avoided; it has not been shown to be more effective and may promote the emergence of resistance organisms.
Current evidence • Recommend routine prescription of macrolide antibiotics in this clinical situation. • The routine prescription of macrolide antibiotic (erythromycin) is recommended as beta lactum antibiotics (augmentin) is associated with a statistically significant increase in neonatal necrotising enterocolitis.